CIBC Private Wealth Group
PLSE icon

CIBC Private Wealth Group’s Pulse Biosciences PLSE Stock Holding History

CIBC Private Wealth Group’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$13.7K Buy
+1,000
New +$15.6K ﹤0.01% 2308

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

CIBC Private Wealth Group's PLSE Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Pulse Biosciences (PLSE) in Q4 2025: 1,000 shares worth $13.7K. The stake represents ﹤0.01% of the portfolio and ranks #2308 among its holdings.

82 funds tracked by Wall St. Rank hold PLSE as of Q4 2025.

  • CIBC Private Wealth Group held 1,000 shares of Pulse Biosciences worth $13.7K as of Q4 2025.
  • Pulse Biosciences was a new CIBC Private Wealth Group position in Q4 2025.
  • Pulse Biosciences made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2308 holding.
  • 82 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.